MedPath

Monitoring of influenza vaccine effectiveness among Japanese children (2020/21 - 2026/27 season)

Not Applicable
Recruiting
Conditions
Influenza
Registration Number
JPRN-UMIN000043402
Lead Sponsor
Osaka Metropolitan University
Brief Summary

Vaccine effectiveness 2022/23 season: 77% for 1 dose, 2% for 2 doses

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
424
Inclusion Criteria

Not provided

Exclusion Criteria

Subjects are excluded if they: - are aged less than 6 months, as of the last October 1st before each season - have a history of anaphylaxis after influenza vaccination - had been administered influenza antivirals for the current ILI - experienced the current ILI during the hospitalization - are institutionalized - are non-residents in Osaka/Fukuoka prefecture, Japan - are judged to be inappropriate for participation by doctors in charge

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath